Jump to content

Pemberton's sign

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by IznoRepeat (talk | contribs) at 03:27, 9 October 2020 (Further reading: per TFD). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Pemberton's sign
Differential diagnosissuperior vena cava syndrome

Pemberton's sign was named after Dr. Hugh Pemberton, who characterized it in 1946.[1]

The Pemberton maneuver is a physical examination tool used to demonstrate the presence of latent pressure in the thoracic inlet.[2] The maneuver is achieved by having the patient elevate both arms (usually 180 degrees anterior flexion at the shoulder) until the forearms touch the sides of the face. A positive Pemberton's sign is marked by the presence of facial congestion and cyanosis, as well as respiratory distress after approximately one minute.[3]

Causes

A positive Pemberton's sign is indicative of superior vena cava syndrome (SVC), commonly the result of a mass in the mediastinum. Although the sign is most commonly described in patients with substernal goiters where the goiter “corks off” the thoracic inlet,[4] the maneuver is potentially useful in any patient with adenopathy, tumor, or fibrosis involving the mediastinum. SVC syndrome has been observed as a result of diffuse mediastinal lymphadenopathy of various pathologies such as cystic fibrosis [5] and Castleman’s disease.[6] Park et al. reported enlarged cervical lymph nodes associated with hemophagocytic lymphohistiocytosis as the cause of internal jugular vein compression, which presented clinically similar to SVC syndrome.[7]

References

  1. ^ Pemberton, HS (1946). "Sign of submerged goitre". Lancet. 248 (6423): 509. doi:10.1016/s0140-6736(46)91790-4.
  2. ^ Wallace, C; Siminoski K (1996). "The Pemberton sign". Ann Intern Med. 125 (7): 568–569. doi:10.7326/0003-4819-125-7-199610010-00006. PMID 8815756. S2CID 32532890.
  3. ^ Pemberton, HS (1946). "Sign of submerged goitre". Lancet. 248 (6423): 509. doi:10.1016/s0140-6736(46)91790-4.
  4. ^ Basaria, S; Salvatori R (2004). "Pemberton's sign". New England Journal of Medicine. 350 (13): 1338. doi:10.1056/nejmicm990287. PMID 15044645.
  5. ^ Chow, J; McKim DA; Shennib, H; et al. (1997). "Superior vena cava obstruction secondary to mediastinal lymphadenopathy in a patient with cystic fibrosis". Chest. 112 (5): 1438–1441. doi:10.1378/chest.112.5.1438. PMID 9367491.
  6. ^ Tekinbas, C; Erol MM; Ozsu S; et al. (2008). "Giant mass due to Castleman's disease causing superior vena cava syndrome". Thorac Cardiovasc Surg. 56 (5): 303–305. doi:10.1055/s-2008-1038408. PMID 18615381.
  7. ^ Park, M; Choi JW; Park HJ; et al. (2012). "Hemophagocytic lymphohistiocytosis can mimic the superior vena cava syndrome". J Pediatr Hematol Oncol. 34 (4): 152–154. doi:10.1097/MPH.0b013e3182422a20. PMID 22395213. S2CID 22479614.

Further reading

  • Abu-Shama Y and Cuny T. Pemberton’s Sign in a Patient with a Goiter. N Engl J Med. 2018;378:e31. DOI: 10.1056/NEJMicm1712263. A short case illustrating Pemberton's sign, with images and a video.